MCHP
Microchip Technology Incorporated
MCHP has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has a slight edge over MCHP overall, supported by stronger fundamentals and stronger valuation.
MCHP Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Stable |
MCHP's revenue, profitability and cash flow are currently strong, and its balance sheet is stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
MCHP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $62.08 | — |
| Cheap | 21x | $28.42 | -54% |
| Fair | 40x | $53.17 | -14% |
| Current | 47x | $62.08 | — |
| Expensive | 104x | $138 | +122% |
Historical ranges are pointers, not guarantees.
MCHP's PE is in its fair range at 47x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its cheap range.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over MCHP in the historical PE scenario, which offers more potential upside but is not a forecast.
MCHP Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for MCHP, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
MCHP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.02 | +202% |
| Q3 2026 | $1.33 | +$1.78 |
| Q2 2026 | $0.68 | +$1.02 |
| Q1 2026 | $0.22 | +$0.23 |
| Q4 2025 | -$0.29 | -151% |
| Q3 2025 | -$0.45 | -131% |
| Q2 2025 | -$0.34 | -114% |
| Q1 2025 | -$0.01 | -100% |
| Q4 2024 | $0.57 | -87% |
MCHP has returned to profit: it earned $1.33 per share over the past year, after losing money the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over MCHP in the latest year-over-year earnings comparison.
MCHP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +42% |
| Q2 2026 | $1.5B | +38% |
| Q1 2026 | $1.3B | +35% |
| Q4 2025 | $1.2B | +16% |
| Q3 2025 | $1.1B | -2% |
| Q2 2025 | $1.1B | -13% |
| Q1 2025 | $970.5M | -27% |
| Q4 2024 | $1B | -42% |
MCHP's revenue is recovering but still below its 2023 peak: $1.6B last quarter, up 42% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +21 points |
| Q2 2026 | 23% | +20 points |
| Q1 2026 | 17% | +27 points |
| Q4 2025 | 13% | +9.8 points |
| Q3 2025 | 7.8% | -4.8 points |
| Q2 2025 | 3% | -15 points |
| Q1 2025 | -10% | -30 points |
| Q4 2024 | 3% | -27 points |
MCHP's operating margin was 29% last quarter, up 21 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over MCHP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over MCHP on profitability, with a higher operating margin.
MCHP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $396.1M | +668% |
| Q2 2026 | $497.6M | +93% |
| Q1 2026 | $242.8M | +27% |
| Q4 2025 | $318.9M | +26% |
| Q3 2025 | $51.6M | +126% |
| Q2 2025 | $257.7M | -15% |
| Q1 2025 | $191.7M | -51% |
| Q4 2024 | $253.4M | -68% |
MCHP has the edge over SNDK on cash flow, with more consistent year-over-year improvement.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
MCHP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +100K shares |
| 1 year | +1% | +5.6M shares |
| 3 years | +0.3% | +1.4M shares |
| 5 years | -2.7% | -15.3M shares |
| Available history | +6.6% | +34M shares |
MCHP has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $6.5M |
| Q3 2024 | $17.3M |
| Q2 2024 | $72.7M |
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
MCHP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 4.5x | High |
| Q4 2025 | 5.9x | High |
| Q3 2025 | 6.7x | High |
| Q2 2025 | 5.8x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.3x | High |
MCHP's net debt is about 2.8 years of its operating earnings (EBITDA), down from 6.7 years a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over MCHP on leverage, with a lower net debt burden relative to earnings.
MCHP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 28.2 | Neutral |
MCHP's weekly RSI is 39 (neutral) and its Stochastic is 28 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
MCHP PE vs Technology Sector
| Metric | MCHP | Sector median | Relative |
|---|---|---|---|
| PE | 47x | 28x | 68% above |
| PE % | 61 | 35 | 26 pts above |
MCHP is trading at 47x earnings, a 68% premium to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over MCHP on valuation relative to its sector.
MCHP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $72.7 | 15% below |
| 20 week MA | $76.2 | 18% below |
| 50 week MA | $77.2 | 20% below |
| 100 week MA | $68.2 | 9% below |
| 200 week MA | $75.2 | 17% below |
SNDK has stronger trend alignment. MCHP is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
MCHP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $52.7 | $68.4 | +30% |
| 2021 | $68.4 | $86.9 | +27% |
| 2022 | $86.9 | $69.9 | -20% |
| 2023 | $69.9 | $90.2 | +29% |
| 2024 | $90.2 | $58.3 | -35% |
| 2025 | $58.3 | $64.9 | +11% |
| 2026 YTD | $64.9 | $62.1 | -4.4% |
MCHP has finished higher in four of the last six years. It's down 4.4% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over MCHP on returns for 2026, with the stronger performance.